$8.5M Seed Round Fuels Geviti's AI-Powered Vision of Proactive Health Optimization
In the quest for a longer, healthier life, we often look to exercise, nutrition, and mental well-being as primary contributors to our overall health. While these are undeniably important, there’s another critical piece of the puzzle that often gets overlooked—bloodwork and biomarker testing. This powerful tool can unlock insights into your body’s internal health, helping you optimize your lifestyle and prevent chronic illnesses. Here's why regular bloodwork and biomarker monitoring are essential for achieving longevity.
23 May 2025 • 3 min read

Table of contents
- Transforming Healthcare from Reactive to Proactive
- Accelerating Innovation with New Funding
- Looking Ahead
We are excited to announce that Geviti has successfully closed our seed funding round, raising $8.5 million in under one month. This milestone represents not just a financial achievement, but a powerful endorsement of our mission to make longevity-centric healthcare accessible to everyone.
Transforming Healthcare from Reactive to Proactive
The traditional healthcare system has long operated on a reactive model, treating symptoms and diseases after they emerge rather than preventing them in the first place. This approach has led to skyrocketing healthcare costs, overwhelmed medical systems, and most importantly, unnecessary suffering that could have been prevented with earlier intervention.
Founded after co-founder Nate Graville experienced firsthand the limitations of reactive healthcare when he lost his father to what was believed to be a largely preventable disease, Geviti was born from the mission to prevent others from facing similar preventable losses.
At Geviti, we're flipping this model on its head. We believe healthcare should be proactive and preventative, focusing on maintaining health and extending quality of life rather than simply managing disease. Our platform leverages cutting-edge technology to identify potential health issues before they become serious problems, empowering individuals to take control of their wellbeing earlier and more effectively.
Accelerating Innovation with New Funding
This $8.5 million seed investment will fuel our next phase of growth, allowing us to:
- Expand our talented team of healthcare experts, data scientists, and engineers
- Accelerate the development of our LLM and machine learning technologies
- Scale our platform to reach more people seeking accessible longevity care
- Forge strategic partnerships within the healthcare ecosystem
The rapid close of our funding round, completed in under a month, signals strong investor confidence in both our vision and our execution strategy. We're particularly grateful to our investment partners who share our passion for democratizing access to longevity science.
Looking Ahead
While we're proud of what we've accomplished so far, we recognize that this is just the beginning of our journey. The healthcare landscape continues to evolve rapidly, particularly in the fields of AI and machine learning. These technologies are transforming what's possible in personalized medicine, predictive analytics, and preventative care.
At Geviti, we're committed to staying at the forefront of these innovations, ensuring that cutting-edge longevity science isn't just available to the privileged few, but accessible to all who seek it.
We believe that everyone deserves the opportunity to live a longer, healthier life. With this new funding, we're one step closer to making that vision a reality.